YCT-529, a hormone-free male birth control pill, has shown high effectiveness in animals and is now in human trials, marking ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical-stage biotechnology company dedicated to treating immune dysregulation, ...

As the indications and demand for glucagon-like peptide-1 (GLP-1) agonist drugs continue to expand, the real-world GLP-1 research and data-driven insights from Prime Therapeutics LLC (Prime) help ...

A groundbreaking male birth control pill, YCT529, is being developed by researchers at the University of Minnesota in ...

A groundbreaking male birth control pill is advancing through clinical trials, marking a major step toward expanding ...

While the FDA has approved over 20 different categories of contraceptives, only two are available for men to prevent ...

Learn more about whether Corcept Therapeutics Incorporated or Viatris Inc. is a better investment based on AAII's A+ Investor ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

Adcendo, a biotech company pioneering the development of first- and potential best-in-class antibody-drug conjugates (ADCs) ...

“A safe and effective male pill will provide more options to couples for birth control,” said Gunda Georg, the corresponding author of the study and a professor in the College of Pharmacy where the ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their greatest lesson from 2024 ...